Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 09:40AM ET
2.91
Dollar change
-0.00
Percentage change
-0.12
%
Index- P/E- EPS (ttm)-6.97 Insider Own29.21% Shs Outstand1.58M Perf Week-17.89%
Market Cap5.29M Forward P/E- EPS next Y- Insider Trans-2.91% Shs Float1.29M Perf Month-14.01%
Income-10.34M PEG- EPS next Q- Inst Own7.13% Short Float3.72% Perf Quarter-46.17%
Sales0.47M P/S11.26 EPS this Y- Inst Trans-65.57% Short Ratio0.31 Perf Half Y-55.66%
Book/sh-1.27 P/B- EPS next Y- ROA-210.81% Short Interest0.05M Perf Year-91.58%
Cash/sh0.52 P/C5.57 EPS next 5Y- ROE-703.62% 52W Range2.62 - 35.40 Perf YTD-70.83%
Dividend Est.- P/FCF- EPS past 5Y30.13% ROI- 52W High-91.79% Beta1.37
Dividend TTM- Quick Ratio0.31 Sales past 5Y100.50% Gross Margin11.11% 52W Low10.94% ATR (14)0.33
Dividend Ex-Date- Current Ratio0.31 EPS Y/Y TTM28.66% Oper. Margin-2224.15% RSI (14)36.82 Volatility11.52% 10.74%
Employees20 Debt/Eq- Sales Y/Y TTM-65.49% Profit Margin-2208.76% Recom2.00 Target Price60.00
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q48.01% Payout- Rel Volume0.04 Prev Close2.91
Sales Surprise- EPS Surprise- Sales Q/Q-14.06% EarningsMay 14 AMC Avg Volume157.10K Price2.91
SMA20-3.91% SMA50-28.86% SMA200-55.29% Trades Volume573 Change-0.12%
Date Action Analyst Rating Change Price Target Change
Apr-16-21Downgrade Dawson James Buy → Neutral
Jul-17-24 07:00AM
Jul-08-24 07:00AM
Jun-10-24 07:32AM
Jun-07-24 07:00AM
Jun-04-24 07:52AM
05:00PM Loading…
May-21-24 05:00PM
May-15-24 03:08AM
May-14-24 08:56PM
04:02PM
May-09-24 07:00AM
May-01-24 07:00AM
Apr-25-24 09:00AM
Apr-02-24 05:41PM
Apr-01-24 02:30PM
Mar-28-24 05:58AM
08:53PM Loading…
Mar-27-24 08:53PM
04:00PM
Mar-20-24 07:00AM
Mar-13-24 07:00AM
Mar-12-24 07:00AM
Mar-04-24 09:27AM
08:00AM
Feb-08-24 07:00AM
Jan-31-24 07:00AM
Jan-03-24 07:00AM
Dec-19-23 07:00AM
Dec-18-23 07:16AM
Nov-29-23 07:00AM
Nov-16-23 12:56PM
Nov-15-23 11:04AM
07:15AM Loading…
Nov-14-23 07:15AM
Nov-09-23 12:48PM
06:59AM
Nov-08-23 05:52PM
05:50PM
04:11PM
Nov-01-23 05:04PM
Oct-12-23 11:08AM
Oct-11-23 06:00AM
Sep-06-23 10:31AM
07:15AM
Sep-05-23 07:15AM
Aug-11-23 09:29AM
Aug-09-23 06:05PM
04:05PM
Aug-02-23 07:00AM
Jul-24-23 07:00AM
Jul-10-23 08:11AM
Jul-05-23 07:00AM
Jun-20-23 05:14PM
Jun-08-23 07:00AM
May-28-23 08:08AM
May-23-23 07:00AM
May-12-23 06:06AM
May-10-23 05:45PM
04:05PM
May-09-23 07:00AM
May-03-23 08:00PM
Apr-28-23 07:00AM
Apr-04-23 07:00AM
Apr-01-23 12:47PM
Mar-31-23 06:05AM
Mar-29-23 08:15AM
Mar-16-23 07:00AM
Mar-06-23 01:06PM
07:00AM
Feb-01-23 06:30AM
Jan-31-23 05:39AM
Dec-22-22 07:00AM
Dec-21-22 05:07AM
Dec-15-22 07:00AM
Dec-06-22 07:00AM
Nov-09-22 05:35PM
04:05PM
12:00PM
Nov-02-22 05:31PM
Oct-03-22 01:33PM
07:00AM
Sep-14-22 07:00AM
Sep-09-22 07:00AM
Sep-08-22 07:00AM
Sep-06-22 11:03AM
Aug-31-22 07:00AM
Aug-24-22 09:40AM
07:00AM
Aug-10-22 05:15PM
04:30PM
04:05PM
Aug-04-22 02:04PM
Aug-01-22 08:00AM
Jul-12-22 08:15AM
Jun-15-22 08:00AM
May-11-22 05:55PM
04:15PM
May-06-22 03:15PM
May-04-22 08:30AM
Apr-13-22 10:25AM
Apr-12-22 07:15AM
Mar-30-22 03:51PM
Mar-29-22 04:05PM
BioCardia, Inc. is a clinical-stage biotherapeutic company. It engages in the business of developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. The company was founded on January 12, 1994 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Altman PeterPresident and CEOJul 01 '24Buy3.0530091539,745Jul 02 04:12 PM
Altman PeterPresident and CEOJun 28 '24Buy2.9920059839,445Jul 02 04:12 PM
Altman PeterPresident and CEOJun 21 '24Buy3.295001,64539,245Jun 24 08:46 AM
Altman PeterPresident and CEOJun 14 '24Buy3.525001,76038,745Jun 17 07:00 AM
Altman PeterPresident and CEOJun 10 '24Buy3.361,0003,36038,245Jun 12 07:00 AM
Altman PeterPresident and CEOApr 19 '24Buy0.372,7501,013558,697Apr 19 05:38 PM
Altman PeterPresident and CEOMar 28 '24Buy0.39500195555,947Mar 28 07:33 PM
Altman PeterPresident and CEOFeb 13 '24Buy0.46108,10850,000555,447Feb 15 07:00 AM
FROST PHILLIP MD ET AL10% OwnerJan 19 '24Sale0.43129,80255,8151,896,025Jan 22 08:38 PM